Published in Br J Dermatol on May 22, 2008
E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog (2011) 1.89
Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ (2010) 1.18
Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg (2012) 1.03
Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types. J Virol (2011) 0.92
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review. J Adolesc Health (2012) 0.89
Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer (2013) 0.89
Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer Med (2014) 0.88
Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses. J Virol (2009) 0.87
Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis (2012) 0.84
Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One (2012) 0.82
The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study. J Invest Dermatol (2014) 0.82
Mucosal and cutaneous human papillomaviruses detected in raw sewages. PLoS One (2013) 0.76
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study. PLoS One (2016) 0.75
Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins. Virology (2016) 0.75
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Conduction at domain walls in oxide multiferroics. Nat Mater (2009) 4.18
Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature (1997) 3.53
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet (1998) 2.52
A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods (2001) 2.15
Treatment outcome and incidence of psychiatric disorders in dermatological out-patients. J Eur Acad Dermatol Venereol (2003) 2.10
Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol (2000) 2.04
Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol (2010) 2.01
A viral enhancer element specifically active in human haematopoietic cells. Nature (1985) 1.95
Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology (2001) 1.93
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer (2010) 1.89
UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science (1999) 1.88
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol (2012) 1.78
Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom (2001) 1.74
Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther (1999) 1.73
Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59
Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J Virol (1990) 1.52
Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles. Lancet (1993) 1.48
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol (2004) 1.46
Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol (2011) 1.45
Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem (1995) 1.40
Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis. Br J Dermatol (2011) 1.39
Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol (1998) 1.36
Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem (2001) 1.32
Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol (2001) 1.30
Galactan-binding antibodies. Diversity and structure of idiotypes. J Exp Med (1983) 1.30
Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol (1991) 1.29
Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol (2006) 1.28
Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol (1998) 1.28
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol (2007) 1.26
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol (2001) 1.22
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev (2008) 1.18
Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology (2007) 1.15
Quality of life and psychological problems of patients with oral mucosal disease in dermatological practice. Dermatology (2009) 1.14
The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J Virol (1993) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Kinetics of the exchange of individual amide protons in the basic pancreatic trypsin inhibitor. J Mol Biol (1979) 1.13
Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom (2003) 1.13
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol (2004) 1.12
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7). Vaccine (2004) 1.11
Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region. Biochem Biophys Res Commun (1990) 1.11
Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. Virology (1995) 1.09
Consequences of a subtle sialic acid modification on the murine polyomavirus receptor. J Virol (1997) 1.08
Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol (2005) 1.06
Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol (1999) 1.05
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett (2010) 1.05
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol (1997) 1.04
Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol (2007) 1.04
Quality of life in patients with epidermolysis bullosa. Br J Dermatol (2009) 1.04
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol (2006) 1.03
The epidemiology of atopic dermatitis in Italian schoolchildren. Allergy (2003) 1.03
Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis. J Virol (1992) 1.02
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Int J Cancer (2000) 1.02
Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas. Int J Cancer (1988) 1.02
A persistent rise in mortality among injection drug users in Rome, 1980 through 1992. Am J Public Health (1997) 1.01
Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res (1998) 1.01
Electrotransfection of human lymphoid and myeloid cell lines. Nucleic Acids Res (1988) 1.01
Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Biol Chem (2001) 1.00
Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer (2013) 1.00
Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology (1999) 1.00
Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J Biol Chem (1999) 0.99
Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med (1993) 0.99
kappa-Chain restriction in anti-galactan antibodies. J Immunol (1982) 0.98
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet (2000) 0.97
Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. J Gen Virol (2011) 0.97
Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol (2001) 0.97
Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood (1998) 0.96
Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol (2001) 0.95
Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol (2000) 0.95
The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. Br J Dermatol (2008) 0.95
Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines. J Virol (1995) 0.94
Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation. J Virol (1994) 0.94
Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients. J Clin Microbiol (1991) 0.93
Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol (2008) 0.91
Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21. Eur J Immunol (1995) 0.90
What proportion of dermatological patients receive evidence-based treatment? Arch Dermatol (2001) 0.90
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy. Clin Cancer Res (1996) 0.90
Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol (2008) 0.90
Genome structure and host range restriction of the lymphotropic papovavirus (LPV): identification of a viral lymphocyte specific enhancer element. Curr Top Microbiol Immunol (1984) 0.90
Financial systems' impact on dental care; a review of fee-for-service and capitation systems. Community Dent Health (2007) 0.89
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells. Int J Cancer (1995) 0.89
A monoclonal antibody that defines an idiotope with two subsites in galactan-binding myeloma proteins. J Exp Med (1981) 0.89
MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma. Int J Cancer (2001) 0.89
Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol (2002) 0.89
Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol (2002) 0.89